|
May 8
|
Anika Announces CFO Transition
|
|
May 8
|
Anika Reports First Quarter 2024 Financial Results
|
|
Apr 25
|
Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago
|
|
Apr 18
|
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
|
|
Apr 11
|
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
|
|
Apr 2
|
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 26
|
Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
|
|
Mar 16
|
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Anika Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
|
|
Mar 14
|
Q4 2023 Anika Therapeutics Inc Earnings Call
|
|
Mar 13
|
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
|
|
Mar 8
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jan 18
|
Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 50% Undervaluation?
|
|
Nov 28
|
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
|
|
Nov 7
|
Anika to Participate in Upcoming Investor Conferences
|
|
Nov 5
|
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Q3 2023 Anika Therapeutics Inc Earnings Call
|
|
Nov 2
|
Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance
|
|
Nov 2
|
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
|
|
Sep 7
|
We're Interested To See How Anika Therapeutics (NASDAQ:ANIK) Uses Its Cash Hoard To Grow
|